Challenge Dementia, supported by Nesta, launches today as the first national search for next generation products, technologies and services that could transform the way people live with dementia helping them to live enjoyable and fulfilling lives for as long as possible.
For several years, neuroscience research using cell line and animal models of degenerative neurological disorders such as Parkinson’s and Alzheimer’s disease has been challenged to translate results into in vivo conditions, whether for basic understanding of disease pathology or for the screening of targeted drug therapies.
The Mast Uri® System is an innovative and efficient semi-automated suite, comprising instrumentation, software and reagents. The system provides a streamlined and cost-friendly alternative to traditional microbiological culture of urines, to aid the diagnosis of urinary tract infections (UTI).
Mast are pleased to announce the latest addition to the mast discs combi range – Carba plus (D73C), a simple and efficient assay for the confirmation of carbapenemase-producing-Enterobacteriaceae (CPE).
A Seattle judge said Olympus Corp. failed to properly disclose internal emails that raised safety concerns about a redesigned medical scope as early as 2008, several years before the device was publicly tied to deadly superbug outbreaks.